- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
- Locations
-
- Anhui Provincial Hospital Anhui, China
- Anyang Tumor Hosptial Anyang, China
- Beijing Cancer Hospital Beijing, China
- Beijing Luhe Hospital Capital Medical University Beijing, China
Clinical trial condition
Head and Neck Neoplasms
Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.
3,775 public trials
1,058 recruiting studies
Head and Neck Neoplasms trial results
NCT05077709
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
- Locations
-
- City of Hope Duarte, California, United States
- UC Davis Cancer Center Sacramento, California, United States
- University of California San Diego San Diego, California, United States
- Mid Florida Hematology and Oncology Center Orange City, Florida, United States
Completed
Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY)
NCT05694819
- Conditions
- Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Nagoya University Hospital Nagoya, Aichi-ken, Japan
- Chiba University Hospital Chiba, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- National Hospital Organization Kyushu Medical Center Fukuoka, Japan
NCT05563480
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- The Fifth Affiliated Hospital Sun Yat sen University Zhuhai, Guangdong, China
- Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
- Union Hospital Tongji Medical College, Huazhong University Of Science And Technology Wuhan, Hubei, China
NCT00213486
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +6 more
- Locations
-
- CHU de Rouen Rouen, France
Completed
Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients
NCT05673577
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- Fudan University Shanghai, China
Completed
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03370276
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma, +14 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University School of Medicine Atlanta, Georgia, United States
- The Ohio State University Columbus, Ohio, United States
NCT02510859
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Service ORL et de chirurgie cervico- faciale Caen CHU, France
NCT05561920
- Conditions
- Behavior, Communication, Head and Neck Neoplasms, +12 more
- Locations
-
- University Hospital Osijek Osijek, Croatia
NCT04785820
- Conditions
- Advanced or Metastatic Esophageal Squamous Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell, +13 more
- Locations
-
- Inst. Alexander Fleming Buenos Aires, Argentina
- Centro Oncologico Riojano Integral (CORI) La Rioja, Argentina
- Hospital das Clinicas - UFRGS Porto Alegre, Rio Grande do Sul, Brazil
- Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo, Brazil